Immediate Impact
2 from Science/Nature 49 standout
Citing Papers
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
2022 Standout
Works of F Turpin being referenced
A phase I clinical and pharmacokinetic study of capecitabine (Xeloda®) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours
2005
Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer.
1994
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| F Turpin | 243 | 8 | 40 | 82 | 81 | 33 | 397 | |
| Greenspan Em | 154 | 17 | 20 | 68 | 66 | 23 | 397 | |
| V. K. Vaitkevicius | 163 | 24 | 30 | 87 | 49 | 22 | 436 | |
| M Namer | 266 | 3 | 49 | 92 | 84 | 36 | 432 | |
| C. L. Vogel | 264 | 4 | 32 | 57 | 89 | 27 | 404 | |
| Ewa Chmielowska | 245 | 3 | 26 | 106 | 57 | 42 | 455 | |
| S. C. Remick | 232 | 18 | 24 | 139 | 55 | 25 | 398 | |
| Alex Y. C. Chang | 169 | 12 | 33 | 129 | 62 | 24 | 422 | |
| Mitsuru Yoshimoto | 177 | 23 | 26 | 135 | 140 | 37 | 425 | |
| Sumie Hiramatsu | 139 | 30 | 48 | 98 | 60 | 36 | 458 | |
| Bill L. Tranum | 231 | 15 | 37 | 46 | 137 | 20 | 422 |
All Works
Loading papers...